vs 5,821 other HR bills in the 113th — cohort avg 49d
Summary
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Lobbying filings that explicitly cite this bill (50)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.
Client expense: $620,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. Medical Innovation Act of 2015
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing.
Client expense: $620,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. Medical Innovation Act of 2015
Client expense: Not reported · Firm income: $30,000
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. Medical Innovation Act of 2015
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
ISSUES National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); cost of diabetes
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR)
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); cost of diabetes
Client expense: $920,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR)
Cited source text, amounts, lobbyists, and targets
340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), HIV education (no specific bill), MODDERN Cures Act of 2013 (H.R. 3116), Prescription Drug User Fee Act (general planning), 21st Century Cures (no specific bill), Strengthening Medicare Anti-Fraud Measures Act of 2013 (H.R. 2925), Big data (general education), Alzheimer's education (no specific bill), biosimilars (general education, no specific bill), general pharmaceutical industry issues and education.
Client expense: $1,160,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.1074/S.539 - National Diabetes Clinical Care Commission Act
S.323/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013
S. 2689/H.R. 5644 - Medicare CGM Access Act of 2014
Client expense: $80,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
S. 2467 National Defense Authorization Act Army Medical
Army Medical Specialty Corps (AMSC)
S. 907/ H.R. 1915 Gestational Diabetes (GEDI) Act
S. 539 National Diabetes Clinical Care Commission Act
H.R. 1074 National Diabetes Clinical Care Commission Act
H.R. 2663/ S. 1422 Preventative Health Savings Act
S. 959 Pharmaceutical Compounding Quality and Accountability Act
Affordable Care Act - Preventative Services
H.R. 6543 Older Americans Act
Client expense: $20,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Cited source text, amounts, lobbyists, and targets
340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), HIV education (no specific bill), MODDERN Cures Act of 2013 (H.R. 3116), Prescription Drug User Fee Act (general planning), 21st Century Cures (no specific bill), Strengthening Medicare Anti-Fraud Measures Act of 2013 (H.R. 2925), Big data (general education), Alzheimer's education (no specific bill), biosimilars (general education, no specific bill), general pharmaceutical industry issues and education.
Client expense: $1,160,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), HIV education (no specific bill), MODDERN Cures Act of 2013 (H.R. 3116), biosimilars (no specific bill), Alzheimer's education (no specific bill)21st Century Cures (no specific bill), general pharmaceutical industry issues and education
Client expense: $490,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions and prescription drug abuse.
1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148)
2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353)
3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5)
4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296)
5.Implementation of the Budget Control Act of 2011 (Public Law 112-25)
6.Delivering Antimicrobial Transparency in Animals Act of 2013 (H.R. 820)
7.Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14)
8.Healthier Lifestyles and Prevention America Act (S. 39)
9.Promoting Health as Youth Skills in Classrooms and Life Act (S. 392/H.R. 2160)
10.Medicare Diabetes Prevention Act (S. 452/H.R. 962)
11.Personal Health Investment Today Act (H.R. 956)
12.A bill to provide for a sequester replacement (S. 16/S. 799)
13.American Family Economic Protection Act of 2013 (S. 388)
14.Consolidated and Further Continuing Appropriations Act, 2013 (H.R. 933/Public Law 113-6)
15.Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (Public Law 113-5)
16.National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539)
17.Physical Activity Guidelines for Americans Act (S. 531/H.R. 2179)
18.Firearm Safety and Public Health Research Act (H.R. 321)
19.Energy Consumers Relief Act (S. 1363/H.R. 1582)
20.Common Sense Nutrition Disclosure Act (H.R. 1249/S. 1756)
21.Improve Nutrition Program Integrity and Deficit Reduction Act (S. 458/H.R. 1510)
22.A bill to amend the Food and Nutrition Act of 2008 to improve the supplemental nutrition assistance program (S. 762/H.R. 1657)
23.Agriculture Reform, Food, and Jobs Act (S. 954/H.R. 2498)
24.Federal Agriculture Reform and Risk Management Act (H.R. 1947)
25.FIT Kids Act (S. 1033/H.R. 2178)
26.Strengthening Americas Schools Act (S. 1094)
27.Access to Quality Diabetes Education Act (S. 945/H.R. 1274)
28.Fit to Serve Act (S. 976)
29.Climate Change Health Protection and Promotion Act (H.R. 2023/S. 2864)
30.Treat and Reduce Obesity Act (S. 1184 / H.R. 2415)
31.Student Success Act (H.R. 5)
32.To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act (H.R. 45)
33.Medicare Better Health Rewards Program Act (S. 1228/H.R. 2524)
34.Senate FY14 Labor, Health and Human Services, and Education Bill (S. 1284)
35.House of Representatives FY14 Labor, Health and Human Services, and Education Bill
36.Pharmacy Compounding Quality and Accountability Act (S. 959)
37.Safeguarding Americas Pharmaceuticals Act (H.R. 1919)
38.Implementation of Drug Supply Chain Security Act (P.L. 113-54)
39.Preservation of Antibiotics for Medical Treatment Act (H.R. 1150)/Preventing Antibiotic Resistance Act of 2013 (S. 1256)
40.Healthy Families Act (H.R. 1286/S. 631)
41.FY2014 Continuing Resolution (H.J. Res. 59)
42.Pharmaceutical Quality, Security and Accountability Act (S. 959)
43.Energy Consumers Relief Act (S. 1363/H.R. 1582)
44.Increasing the Safety of Prescription Drug Use Act (S. 1657)
45.National Energy Tax Repeal Act (S. 1324)
46.Saving Coal Jobs Act of 2013 (S. 1514/H.R. 5077)
47.Community Parks Revitalization Act (H.R. 2424)
48.A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings (S. 1422/H.R. 2663)
49.School-based Health Centers Program Reauthorization Act of 2013 (H.R. 2632)
50.Nutrition Reform and Work Opportunity Act (H.R. 3102)
51.Health Equity and Accountability Act (H.R. 5294)
52.Secure America for Education (SAFE) in Our Schools Act of 2013 (H.R. 3158)
53.Continuing Appropriations Resolution, 2014 (H.J. Res 59)
54.Continuing Resolution FY 2014 (HR 2775, PL 113-46)
55.A bill to amend title 23, United States Code, with respect to the establishment of performance measures for the highway safety improvement program, and for other purposes. (H.R. 3493/S. 1708)
56.The Farm Bill (S. (S. 954/H.R. 2498; H.R. 1947, and H.R. 3102, Public Law 113-79)
57.Better Care, Lower Cost Act (S. 1932/H.R. 3890)
58.Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) (H.R. 3742)
59.The Consolidated Appropriations Act of 2014 (H.R. 3547/Public Law 113-76
60.Strategies to Address Antimicrobial Resistance (STAAR) Act (S. 2236/H.R. 2285)
61.New Opportunities for Bicycling and Pedestrian Infrastructure Financing Act of 2014 (H.R. 3978)
62.Eliminating Disparities in Diabetes Prevention, Access, and Care Act (H.R. 3322)
63.Electricity Security and Affordability Act (S. 1905/H.R. 3826)
64.Stop Overdose Stat Act (HR 4169)
65.Overdose Prevention Act (S 2755)
66.Opioid Overdose Reduction Act (S. 2092/H.R. 4288)
67.Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 (DISARM Act) (H.R. 4187)
68.Child Care and Development Block Grant Act of 2014 (S. 1086)
69.Departments of Labor, Health and Human Services and Education And Related Agencies Fiscal Year 2015 Appropriations Bill (including H.R. 5464)
70.Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 (S. 2389 / H.R. 4800)
71.Department of the Interior, Environment, and Related Agencies appropriations legislation, 2015 (including H.R. 5171)
72.MAP-21 Reauthorization Act (S. 2322)
73.Stop Subsidizing Childhood Obesity Act (S. 2342/H.R. 2831)
74.ENRICH Act (H.R. 4427)
75.Healthy Kids Outdoors Act of 2014 (S. 2367/H.R. 4706)
76.Summer Meals Act of 2014 (S. 2527/HR. 5012)
77.Long-Term SCORE Act (H.R. 4444)
78.American Cures Act (S. 2115/H.R. 4384)
79.A joint resolution to disapprove a rule of the Environmental Protection Agency relating to greenhouse gas emissions from electric utility generating units. (S.J. Res 30)
80.Fit for Life Act of 2014 (H.R.4765)
81.School Food Modernization Act (S. 2210/H.R. 1783)
82.Protecting Children from Electronic Cigarette Advertising Act of 2014 (S. 2014/H.R. 4325)
83.Pedestrian Safety Act of 2014 (S. 2284)
84.Safe Streets Act of 2014 (S. 2004/H.R. 2468)
85.Time for Recovery Enhancement for Addiction Treatment Act (S. 2645)
86.FY 2015 Financial Services and General Government Appropriations bill, in support of an appropriation for the National Alliance for Model State Drug Laws (including H.R. 5016)
87.Vector-Borne Disease Research Accountability and Transparency Act (H.R. 4701)
88.Highway and Transportation Funding Act of 2014 (H.R. 5021/Public Law 113-159)
89.Full-Service Community Schools Act of 2014 (H.R. 5168)
90.PREPARE Act of 2014 (H.R. 5314)
91.Waters of the United States Regulatory Overreach Protection Act of 2014 (S. 2496/H.R. 5078)
92.American Energy Solutions for Lower Costs and More American Jobs Act (H.R. 2)
93.FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act (H.R. 83/Public Law 113-234)
94.Promise for Antibiotics and Therapeutics for Health Act (PATH Act, S. 2996)
95.Infectious Disease Hospital Hubs Act (S. 2942)
Client expense: $39,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), HIV education (no specific bill), MODDERN Cures Act of 2013 (H.R. 3116), Prescription Drug User Fee Act (general planning), 21st Century Cures (no specific bill), Strengthening Medicare Anti-Fraud Measures Act of 2013 (H.R. 2925), Big data (general education), Alzheimer's education (no specific bill), biosimilars (general education, no specific bill), general pharmaceutical industry issues and education.
Client expense: $1,160,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ISSUES National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal). P.L. 113-93 Protecting Access to Medicare Act of 2014 (Special Diabetes Program reauthorization)
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
ISSUES National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal). P.L. 113-93 Protecting Access to Medicare Act of 2014 (Special Diabetes Program reauthorization)
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
S. 2839, Comprehensive Addiction and Recovery Act of 2014, all provisions
S. 2645, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions
H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs, and for other purposes, all provisions
H.R. 1074, National Diabetes Clinical Care Commission Act, all provisions
S. 539, National Diabetes Clinical Care Commission Act, all provisions
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
Affordable Care Act - implementation
Ebola
Prescription requirements for OTC medications
Electronic Health Records - Meaningful Use
ICD-10 Repeal
Prescription Drug Diversion
Prescription drug abuse/pain management/prescriber education
Telemedicine
Sunshine Act
Laboratory Developed Tests
21st Century Cures Initiative
Narrow Networks
Mental Health
Diabetes
Antibiotics and data collection
Personalized medicine
Coverage of lung cancer screening for high-risk patients
Drug Quality and Security Act/Compounded and Repackaged Medications
Federal scientists and researchers - academic and scientific conference travel restrictions
Men who have sex with men/blood donor deferral policy
Client expense: $4,390,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), HIV education (no specific bill), MODDERN Cures Act of 2013 (H.R. 3116), biosimilars (no specific bill), Alzheimer's education (no specific bill)21st Century Cures (no specific bill), general pharmaceutical industry issues and education
Client expense: $460,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- Issues related to ensuring quality of supply chain for FDA regulated products.
- Issues related to Accountable Care Organizations.
- PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions.
- Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit.
- Issues related to maintaining the biosimilars statute without changes.
- HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions.
- S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions.
- S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions.
- Issues related to personalized medicine incentives and regulation.
- Issues related to Moddern Cures initiative.
- Issues related to modernizing laboratory test standards.
- Issues related to diagnostic payments.
- PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage.
- PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions.
- Issues related to the repeal and/or reform of Independent Payment Advisory Boards.
- Issues related to hepatitis C testing and treatment guidelines.
- PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding.
- Issues related to drug resistant tuberculosis.
- Issues related to legislation that would establish drug importation.
- Issues related to legislation that would establish a rebate in the Medicare Part D program.
- Issues related to legislation that would modify the Medicare Part B drug reimbursement program.
- Issues related to medical device reprocessing.
- Issues related to health care pricing transparency.
- HR 3303, "Mobile Medical Application", regarding all provisions.
- Issues related to health care associated inflation policy.
- HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions.
- HR 3204, "Drug Quality and Security Act", regarding all provisions.
- Issues related to neglected tropical diseases.
- Issues related to transferable market exclusivity.
- Issues related to health care associated infections.
- S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions.
- Issues related to FDA regulation of custom medical devices.
- Issues related to Tricare coverage of Total Disc Arthroplasty.
- Issues related to VA requirements for vendor access and credentialing.
- Issues related to 21st Century Cures.
- Issues related to Medicare beneficiary access.
- Issues related to mobile medical applications and digital healthcare.
- Issues related to FDA draft guidances on blood glucose meters.
- HR 4895/ S 2902, "The Microbead Free Waters Act of 2014", regarding all provisions.
- Issues related to the expanded use of unapproved drugs.
- Issues related to combination products.
- Issues related to the PROTECT Act (bill number pending), specifically medical mobile applications.
- Issues related to Government Health Care Exclusion/ Debarment (bill number pending)
- S 2977, "MEDTECH Act", regarding provisions related to medical mobile applications.
- S 2917, "Adding Ebola to the FDA Priority Review Voucher Program Act", regarding all provisions.
Client expense: $1,400,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014
Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening
Human growth hormone and rare disease matters
HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013
HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013
HR 1915/S 907 - Gestational Diabetes Act of 2013
Client expense: Not reported · Firm income: $27,000
Cited source text, amounts, lobbyists, and targets
Diabetes Prevention & Treatment, including related provisions of HR 3322, The Eliminating Disparities in Diabetes Prevention, Access and Care Act of 2013 and HR 1074, The National Diabetes Clinical Care Commission Act.
Client expense: Not reported · Firm income: $50,000
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under Pub. L. 111-148, the Patient Protection and Affordable Care Act of 2009 (ACA) and Pub. L. 111-152, the Health Care and Education Affordability Reconciliation Act of 2010; Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting ("Catalyst for Better Diabetes"); H.R. 1074 and S. 539, the National Diabetes Clinical Care Commission Act of 2013; H.R. 8, the American Taxpayer Relief Act(Special Diabetes Program reauthorization); H.R. 351 and S. 351, the Protecting Seniors'Access to Medicare Act of 2013 (IPAB repeal); Diabetes screening recommendations under USPSTF.
Client expense: Not reported · Firm income: $60,000
Cited source text, amounts, lobbyists, and targets
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
H.R.1074/S.539 - National Diabetes Clinical Care Commission Act
S.323/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013
S. 2689/H.R. 5644 - Medicare CGM Access Act of 2014
Client expense: $60,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1074 - National Diabetes Clinical Care Commission Act
H.R. 1248 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts
H.R. 1281 - Newborn Screening Saves Lives Reauthorization Act
H.R. 3230 - Veterans' Access to Care through Choice, Accountability, and Transparency Act
H.R. 3742 - Antibiotic Development to Advance Patient Treatment Act; provisions related to antibiotics and drug approval
H.R. 4260 - Ryan White Patient Equity and Choice Act; provisions related to ADAP
H.R. 4847 - End Neglected Tropical Diseases Act
S. 539 - National Diabetes Clinical Care Commission Act
S. 610 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts
S. 1165 - Access to Appropriate Immunizations for Veterans Act of 2013; provisions related to extending VA performance measure to include all federally recommended vaccine
S. 1417 - Newborn Screening Saves Lives Reauthorization Act
S. 2917 - Adding Ebola to the FDA Priority Review Voucher Program Act
No bill # assigned - Implementation issues relating to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking
No bill # assigned - 21st Century Cures Initiative and related policy issues
No bill # assigned - FDA special medical use; issues related to limited population antibacterial drug approval pathway
No bill # assigned - FDA accelerated approval policy issues
No bill # assigned - Comparative effectiveness policy issues
No bill # assigned - Biopharmaceutical innovation policy issues
No bill # assigned - Pharmaceutical supply chain security issues
No bill # assigned - 340B policy issues
No bill # assigned - Implementation issues relating to the Physician Payment Sunshine Act
No bill # assigned - Support for COPD national action plan
No bill # assigned - FDA proposed rule regarding generic drug labeling under the 1984 Hatch-Waxman amendments to the FDCA
No bill # assigned - FDA proposed rule regarding Electronic Distribution of Content of Labeling for Human Prescription Drug and Biological Products
Client expense: $580,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES 489, S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 4302, Protecting Access to Medicare Act; S. 2157, Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; H.R. 3322, Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal); cost of diabetes
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; and community-based public health interventions and prescription drug abuse.
1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148)2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353)
3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5)
4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296)
5.Implementation of the Budget Control Act of 2011 (Public Law 112-25)
6.Delivering Antimicrobial Transparency in Animals Act of 2013 (H.R. 820)
7.Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14)
8.Healthier Lifestyles and Prevention America Act (S. 39)
9.Promoting Health as Youth Skills in Classrooms and Life Act (S. 392/H.R. 2160)
10.Medicare Diabetes Prevention Act (S. 452/H.R. 962)
11.Personal Health Investment Today Act (H.R. 956)
12.A bill to provide for a sequester replacement (S. 16/S. 799)
13.American Family Economic Protection Act of 2013 (S. 388)
14.Consolidated and Further Continuing Appropriations Act, 2013 (H.R. 933/Public Law 113-6)
15.Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (Public Law 113-5)
16.National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539)
17.Physical Activity Guidelines for Americans Act (S. 531/H.R. 2179)
18.Firearm Safety and Public Health Research Act (H.R. 321)
19.Energy Consumers Relief Act (S. 1363/H.R. 1582)
20.Common Sense Nutrition Disclosure Act (H.R. 1249/S. 1756)
21.Improve Nutrition Program Integrity and Deficit Reduction Act (S. 458/H.R. 1510)
22.A bill to amend the Food and Nutrition Act of 2008 to improve the supplemental nutrition assistance program (S. 762/H.R. 1657)
23.Agriculture Reform, Food, and Jobs Act (S. 954/H.R. 2498)
24.Federal Agriculture Reform and Risk Management Act (H.R. 1947)
25.FIT Kids Act (S. 1033/H.R. 2178)
26.Strengthening Americas Schools Act (S. 1094)
27.Access to Quality Diabetes Education Act (S. 945/H.R. 1274)
28.Fit to Serve Act (S. 976)
29.Climate Change Health Protection and Promotion Act (H.R. 2023/S. 2864)
30.Treat and Reduce Obesity Act (S. 1184 / H.R. 2415)
31.Student Success Act (H.R. 5)
32.To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act (H.R. 45)
33.Medicare Better Health Rewards Program Act (S. 1228/H.R. 2524)
34.Senate FY14 Labor, Health and Human Services, and Education Bill (S. 1284)
35.House of Representatives FY14 Labor, Health and Human Services, and Education Bill
36.Pharmacy Compounding Quality and Accountability Act (S. 959)
37.Safeguarding Americas Pharmaceuticals Act (H.R. 1919)
38.Implementation of Drug Supply Chain Security Act (P.L. 113-54)
39.Preservation of Antibiotics for Medical Treatment Act (H.R. 1150)/Preventing Antibiotic Resistance Act of 2013 (S. 1256)
40.Healthy Families Act (H.R. 1286/S. 631)
41.FY2014 Continuing Resolution (H.J. Res. 59)
42.Pharmaceutical Quality, Security and Accountability Act (S. 959)
43.Energy Consumers Relief Act (S. 1363/H.R. 1582)
44.Increasing the Safety of Prescription Drug Use Act (S. 1657)
45.National Energy Tax Repeal Act (S. 1324)
46.Saving Coal Jobs Act of 2013 (S. 1514/H.R. 5077)
47.Community Parks Revitalization Act (H.R. 2424)
48.A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings (S. 1422/H.R. 2663)
49.School-based Health Centers Program Reauthorization Act of 2013 (H.R. 2632)
50.Nutrition Reform and Work Opportunity Act (H.R. 3102)
51.Health Equity and Accountability Act (H.R. 5294)
52.Secure America for Education (SAFE) in Our Schools Act of 2013 (H.R. 3158)
53.Continuing Appropriations Resolution, 2014 (H.J. Res 59)
54.Continuing Resolution FY 2014 (HR 2775, PL 113-46)
55.A bill to amend title 23, United States Code, with respect to the establishment of performance measures for the highway safety improvement program, and for other purposes. (H.R. 3493/S. 1708)
56.The Farm Bill (S. (S. 954/H.R. 2498; H.R. 1947, and H.R. 3102, Public Law 113-79)
57.Better Care, Lower Cost Act (S. 1932/H.R. 3890)
58.Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) (H.R. 3742)
59.The Consolidated Appropriations Act of 2014 (H.R. 3547/Public Law 113-76
60.Strategies to Address Antimicrobial Resistance (STAAR) Act (S. 2236/H.R. 2285)
61.New Opportunities for Bicycling and Pedestrian Infrastructure Financing Act of 2014 (H.R. 3978)
62.Eliminating Disparities in Diabetes Prevention, Access, and Care Act (H.R. 3322)
63.Electricity Security and Affordability Act (S. 1905/H.R. 3826)
64.Stop Overdose Stat Act (HR 4169)
65.Overdose Prevention Act (S 2755)
66.Opioid Overdose Reduction Act (S. 2092/H.R. 4288)
67.Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 (DISARM Act) (H.R. 4187)
68.Child Care and Development Block Grant Act of 2014 (S. 1086)
69.Departments of Labor, Health and Human Services and Education And Related Agencies Fiscal Year 2015 Appropriations Bill (including H.R. 5464)
70.Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 (S. 2389 / H.R. 4800)
71.Department of the Interior, Environment, and Related Agencies appropriations legislation, 2015 (including H.R. 5171)
72.MAP-21 Reauthorization Act (S. 2322)
73.Stop Subsidizing Childhood Obesity Act (S. 2342/H.R. 2831)
74.ENRICH Act (H.R. 4427)
75.Healthy Kids Outdoors Act of 2014 (S. 2367/H.R. 4706)
76.Summer Meals Act of 2014 (S. 2527/HR. 5012)
77.Long-Term SCORE Act (H.R. 4444)
78.American Cures Act (S. 2115/H.R. 4384)
79.A joint resolution to disapprove a rule of the Environmental Protection Agency relating to greenhouse gas emissions from electric utility generating units. (S.J. Res 30)
80.Fit for Life Act of 2014 (H.R.4765)
81.School Food Modernization Act (S. 2210/H.R. 1783)
82.Protecting Children from Electronic Cigarette Advertising Act of 2014 (S. 2014/H.R. 4325)
83.Pedestrian Safety Act of 2014 (S. 2284)
84.Safe Streets Act of 2014 (S. 2004/H.R. 2468)
85.The Recovery Enhancement for Addiction Treatment Act (S. 2645)
86.FY 2015 Financial Services and General Government Appropriations bill, in support of an appropriation for the National Alliance for Model State Drug Laws (including H.R. 5016)
87.Vector-Borne Disease Research Accountability and Transparency Act (H.R. 4701)
88.Highway and Transportation Funding Act of 2014 (H.R. 5021/Public Law 113-520)
89.Full-Service Community Schools Act of 2014 (H.R. 5168)
90.PREPARE Act of 2014 (H.R. 5314)
91.Waters of the United States Regulatory Overreach Protection Act of 2014 (S. 2496/H.R. 5078)
92.American Energy Solutions for Lower Costs and More American Jobs Act (H.R.
Client expense: $38,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Client expense: Not reported · Firm income: $50,000
Cited source text, amounts, lobbyists, and targets
ISSUES National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal). P.L. 113-93 Protecting Access to Medicare Act of 2014 (Special Diabetes Program reauthorization)
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), HIV education (no specific bill), MODDERN Cures Act of 2013 (H.R. 3116),Prescription Drug User Fee Act (general planning), 21st Century Cures (no specific bill), Strengthening Medicare Anti-Fraud Measures Act of 2013 (H.R. 2925), Big data (general education), Alzheimer's education (no specific bill), biosimilars (general education, no specific bill), general pharmaceutical industry issues and education.
Client expense: $1,160,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Diabetes Prevention & Treatment, including related provisions of HR 3322, The Eliminating Disparities in Diabetes Prevention, Access and Care Act of 2013 and HR 1074, The National Diabetes Clinical Care Commission Act.
Client expense: Not reported · Firm income: $100,000
Cited source text, amounts, lobbyists, and targets
H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
- Issues related to ensuring quality of supply chain for FDA regulated products.
- Issues related to Accountable Care Organizations.
- PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions.
- Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit.
- Issues related to maintaining the biosimilars statute without changes.
- HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions.
- S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions.
- S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions.
- Issues related to personalized medicine incentives and regulation.
- Issues related to Moddern Cures initiative.
- Issues related to modernizing laboratory test standards.
- Issues related to diagnostic payments.
- PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage.
- PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions.
- Issues related to the repeal and/or reform of Independent Payment Advisory Boards.
- Issues related to hepatitis C testing and treatment guidelines.
- PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding.
- Issues related to drug resistant tuberculosis.
- Issues related to legislation that would establish drug importation.
- Issues related to legislation that would establish a rebate in the Medicare Part D program.
- Issues related to legislation that would modify the Medicare Part B drug reimbursement program.
- Issues related to medical device reprocessing.
- Issues related to health care pricing transparency.
- HR 3303, "Mobile Medical Application", regarding all provisions.
- Issues related to health care associated inflation policy.
- HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions.
- HR 3204, "Drug Quality and Security Act", regarding all provisions.
- Issues related to neglected tropical diseases.
- Issues related to transferable market exclusivity.
- Issues related to health care associated infections.
- S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions.
- Issues related to FDA regulation of custom medical devices.
- Issues related to Tricare coverage of Total Disc Arthroplasty.
- Issues related to VA requirements for vendor access and credentialing.
- Issues related to 21st Century Cures.
- Issues related to Medicare beneficiary access.
- Issues related to mobile medical applications and digital healthcare.
- Issues related to FDA draft guidances on blood glucose meters.
- HR 4895/ S 2902, "The Microbead Free Waters Act of 2014", regarding all provisions.
- Issues related to the expanded use of unapproved drugs.
- Issues related to combination products.
- Issues related to the PROTECT Act (bill number pending), specifically medical mobile applications.
- Issues related to Government Health Care Exclusion/ Debarment (bill number pending)
Client expense: $1,350,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014
Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening
Human growth hormone and rare disease matters
HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013
HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013
HR 1915/S 907 - Gestational Diabetes Act of 2013
Client expense: Not reported · Firm income: $27,000
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under Pub. L. 111-148, the Patient Protection and Affordable Care Act of 2009 (ACA) and Pub. L. 111-152, the Health Care and Education Affordability Reconciliation Act of 2010; Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting ("Catalyst for Better Diabetes"); H.R. 1074 and S. 539, the National Diabetes Clinical Care Commission Act of 2013; H.R. 8, the American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 351 and S. 351, the Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal); Diabetes screening recommendations under USPSTF.
Client expense: Not reported · Firm income: $70,000
Cited source text, amounts, lobbyists, and targets
H.R. 1074- National Diabetes Clinical Care Commission Act
H.R. 1248 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts
H.R. 1281 - Newborn Screening Saves Lives Reauthorization Act
H.R. 3230 - Veterans' Access to Care through Choice, Accountability, and Transparency Act
H.R. 3742 - Antibiotic Development to Advance Patient Treatment Act; provisions related to antibiotics and drug approval
H.R. 4260 - Ryan White Patient Equity and Choice Act; provisions related to ADAP
H.R. 4847 - End Neglected Tropical Diseases Act
S. 539 - National Diabetes Clinical Care Commission Act
S. 610 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts
S. 1165 - Access to Appropriate Immunizations for Veterans Act of 2013; provisions related to extending VA performance measure to include all federally recommended vaccine
S. 1417 - Newborn Screening Saves Lives Reauthorization Act
No bill # assigned - Implementation issues relating to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking
No bill # assigned - 21st Century Cures Initiative and related policy issues
No bill # assigned - FDA special medical use; issues related to limited population antibacterial drug approval pathway
No bill # assigned - FDA accelerated approval policy issues
No bill # assigned - Comparative effectiveness policy issues
No bill # assigned - Biopharmaceutical innovation policy issues
No bill # assigned - Pharmaceutical supply chain security issues
No bill # assigned - 340B policy issues
No bill # assigned - Implementation issues relating to the Physician Payment Sunshine Act
No bill # assigned - Support for COPD national action plan
No bill # assigned - FDA proposed rule regarding generic drug labeling under the 1984 Hatch-Waxman amendments to the FDCA
No bill # assigned - FDA proposed rule regarding electronic distribution of cContent of Labeling for Human Prescription Drug and Biological products
Client expense: $1,140,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.1074/S.539 - National Diabetes Clinical Care Commission Act
S.323/H.R. 1428 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
S. 945/H.R. 1274 - Access to Quality Diabetes Education Act of 2013
S. 2689/H.R. 5644 - Medicare CGM Access Act of 2014
Client expense: $80,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 5380 The Medicare Telehealth Parity Act of 2014
S. 2552 The Medicare Advantage Participants Bill of Rights Act
H.R. 4998, The Medicare Advantage Participants Bill of Rights Act
S. 2553 The Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act)
H.R. 4994, The Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act)
S. 1932 The Better Care, Lower Cost Act
H.R. 3890, The Better Care, Lower Cost Act
S. 1422 The Preventive Health Savings Act
H.R. 2663, The Preventive Health Savings Act
H.R. 5279, The Sugar-Sweetened Beverages Tax (SWEET) Act
S.2574, The Healthy Families Act of 2014
H.R. 1024, The Medication Therapy Management Empowerment Act
S. 2240, The Medicare Choices Empowerment and Protection Act
S. 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014
H.R. 4015 SGR Repeal and Medicare Provider Payment Modernization Act of 2014
HR. 4418, the Expanding the Availability of Medicare Data Act
H.R. 2843 Medicare Data Access for Transparency and Accountability Act
S. 1180 Medicare Data Access for Transparency and Accountability Act
H.R. 3077, TELEmedicine for MEDicare (TELE-MED) Act
H.R. 4190, a bill that would will allow Medicare reimbursement for Part B services performed by a pharmacist in underserved communities, among other activities.
H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013
H.R. 1074 National Diabetes Clinical Care Commission Bill
S. 539, National Diabetes Clinical Care Commission Bill
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES 489, S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 4302, Protecting Access to Medicare Act; S. 2157, Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; H.R. 3322, Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Client expense: $910,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes);H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Client expense: Not reported · Firm income: $70,000
Cited source text, amounts, lobbyists, and targets
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Client expense: Not reported · Firm income: $40,000
Cited source text, amounts, lobbyists, and targets
Diabetes Prevention & Treatment, including related provisions of HR 3322, The Eliminating Disparities in Diabetes Prevention, Access and Care Act of 2013 and HR 1074, The National Diabetes Clinical Care Commission Act.
Client expense: Not reported · Firm income: $30,000
Cited source text, amounts, lobbyists, and targets
Alzheimer's education (no specific bill), 340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), general pharmaceutical industry education, OTC medicines - dextromethorpan and pseudoephedrine (no specific bill).
Client expense: $1,170,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
ISSUES National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal). P.L. 113-93 Protecting Access to Medicare Act of 2014 (Special Diabetes Program reauthorization)
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; and community-based public health interventions.
1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148)1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148)
2.Middle Class Tax Relief and Job Promotion Act (H.R. 3630)
3.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353)
4.Implementation of Pandemic and All-Hazards Preparedness Act (Public Law 109-417)
5.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296)
6.Implementation of the Budget Control Act of 2011 (Public Law 112-25)
7.Delivering Antimicrobial Transparency in Animals Act of 2013 (H.R. 820)
8.Animal Drug and Animal Generic Drug User Fee Act (S. 622/H.R.___)
9.Healthier Lifestyles and Prevention America Act (S. 39)
10.Promoting Health as Youth Skills in Classrooms and Life Act (S. 392)
11.Medicare Diabetes Prevention Act (S. 452/H.R. 962)
12.Personal Health Investment Today Act (H.R. 956)
13.A bill to provide for a sequester replacement (S. 16)
14.American Family Economic Protection Act of 2013 (S. 388)
15.Consolidated and Further Continuing Appropriations Act, 2013 (H.R. 933)
16.Regulations From the Executive in Need of Scrutiny Act of 2013 (S. 15 / H.R. 367)
17.To repeal the Prevention and Public Health Fund (H.R. 1099)
18.Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (Public Law 113-5)
19.National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539)
20.Physical Activity Guidelines for Americans Act (S. 531)
21.Firearm Safety and Public Health Research Act (H.R. 321)
22.Helping Sick Americans Now Act (H.R. 1549)
23.Energy Consumers Relief Act (H.R. 1582)
24.Common Sense Nutrition Disclosure Act (H.R. 1249)
25.Improve Nutrition Program Integrity and Deficit Reduction Act (S. 458/H.R. 1510)
26.A bill to amend the Food and Nutrition Act of 2008 to improve the supplemental nutrition assistance program (S. 762/H.R. 1657)
27.Agriculture Reform, Food, and Jobs Act (S. 954/H.R. 2498)
28.Federal Agriculture Reform and Risk Management Act (H.R. 1947)
29.FIT Kids Act (S. 1033/H.R. 2178)
30.Strengthening Americas Schools Act (S. 840)
31.Access to Quality Diabetes Education Act (S. 945/H.R. 1274)
32.Fit to Serve Act (S. 976)
33.Climate Change Health Protection and Promotion Act (H.R. 2023)
34.Treat and Reduce Obesity Act (S. 1184 / H.R. 2415)
35.Student Success Act (H.R. 5)
36.To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act (H.R. 45)
37.Medicare Better Health Rewards Program Act (S. 1228/H.R. 2524)
38.Senate FY14 Labor, Health and Human Services, and Education Bill
39.House of Representatives FY14 Labor, Health and Human Services, and Education Bill
40.Pharmacy Compounding Quality and Accountability Act (S. 959)
41.Safeguarding Americas Pharmaceuticals Act (H.R. 1919)
42.Drug Supply Chain Security Act (S. 957)
43.Preservation of Antibiotics for Medical Treatment Act (H.R. 1150)/Preventing Antibiotic Resistance Act of 2013 (S. 1256)
44.Healthy Families Act (H.R. 1286/S. 631)
45.FY2014 Continuing Resolution (H.J. Res. 59)
46.Drug Quality and Security Act (H.R. 3204)
47.Pharmaceutical Quality, Security and Accountability Act (S. 959)
48.Energy Consumers Relief Act (H.R. 1582)
49.Increasing the Safety of Prescription Drug User Act (not yet introduced proposed by Sen. Udall-NM)
50.National Energy Tax Repeal Act (S. 1324)51.Saving Coal Jobs Act of 2013 (S. 1514)
52.Community Parks Revitalization Act (H.R. 2424)
53.A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings (S. 1422/H.R. 2663)
54.School-based Health Centers Program Reauthorization Act of 2013 (H.R. 2632)
55.Nutrition Reform and Work Opportunity Act (H.R. 3102)
56.Health Equity and Accountability Act (not yet introduced)
57.Secure America for Education (SAFE) in Our Schools Act of 2013 (H.R. 3158)
58.Continuing Appropriations Resolution, 2014 (H.J. Res 59)
59.Continuing Resolution FY 2014 (HR 2775, PL 113-46)
60.A bill to amend title 23, United States Code, with respect to the establishment of performance measures for the highway safety improvement program, and for other purposes. (H.R. 3493/S. 1708)
61.The Farm Bill (S. (S. 954/H.R. 2498; H.R. 1947, and H.R. 3102)
62.Better Care, Lower Cost Act (S. 1932/H.R. 3890)
63.Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) (H.R. 3742)
64.Preventing Antibiotic Resistance Act (S. 1256)
65.The Consolidated Appropriations Act of 2014
66.Strategies to Address Antimicrobial Resistance (STAAR) Act
67.New Opportunities for Bicycling and Pedestrian Infrastructure Financing Act of 2014 (H.R. 3978)
68.Eliminating Disparities in Diabetes Prevention, Access, and Care Act (H.R. 3322)
69.Electricity Security and Affordability Act (HR 3826)
70.Stop Overdose Stat Act (HR 4169) and Senate companion bill soon to be introduced by Senator Reed
71.Opioid Overdose Reduction Act (S. 2092/H.R. 4288)
72.Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 (DISARM Act) (H.R. 4186)
73.Child Care and Development Block Grant Act of 2014 (S. 1086)
74.Departments of Labor, Health and Human Services and Education And Related Agencies Fiscal Year 2015 Appropriations Bill
75.Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 (S. 2389 / H.R. 4800)
76.Department of the Interior, Environment, and Related Agencies appropriations legislation, 2015
77.MAP-21 Reauthorization Act (S. 2322)
78.Stop Subsidizing Childhood Obesity Act (S. 2342/H.R. 2831)
79.ENRICH Act (H.R. 4427)
80.Agricultural Act of 2014 (Public Law 113-79)
81.Healthy Kids Outdoors Act of 2014 (S. 2367/H.R. 4706)
82.A bill to amend the Richard B. Russell National School Lunch Act to improve the efficiency of summer meals (S. 2527)
83.Summer Meals Act of 2014 (HR. 5012)
84.Long-Term SCORE Act (H.R. 4444)
85.American Cures Act (S. 2115/H.R. 4384)
86.A joint resolution to disapprove a rule of the Environmental Protection Agency relating to greenhouse gas emissions from electric utility generating units. (S.J. Res 30)
87.Fit for Life Act of 2014 (H.R.4765)
88.School Food Modernization Act (S. 2210/H.R. 1783)
89.Protecting Children from Electronic Cigarette Advertising Act of 2014 (S. 2014/H.R. 4325)
90.Pedestrian Safety Act of 2014 (S. 2284)
91.Safe Streets Act of 2014 (S. 2004/H.R. 2468)
92.The Recovery Enhancement for Addiction Treatment Act (not yet introduced, by Senator Markey)
93.FY 2015 Financial Services and General Government Appropriations bill, in support of an appropriation for the National Alliance for Model State Drug Laws
Client expense: $38,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
- Issues related to ensuring quality of supply chain for FDA regulated products.
- Issues related to Accountable Care Organizations.
- PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions.
- Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit.
- Issues related to maintaining the biosimilars statute without changes.
- HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions.
- S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions.
- S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions.
- Issues related to personalized medicine incentives and regulation.
- Issues related to Moddern Cures initiative.
- Issues related to modernizing laboratory test standards.
- Issues related to diagnostic payments.
- PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage.
- PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions.
- Issues related to the repeal and/or reform of Independent Payment Advisory Boards.
- Issues related to hepatitis C testing and treatment guidelines.
- PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding.
- Issues related to drug resistant tuberculosis.
- Issues related to legislation that would establish drug importation.
- Issues related to legislation that would establish a rebate in the Medicare Part D program.
- Issues related to legislation that would modify the Medicare Part B drug reimbursement program.
- Issues related to medical device reprocessing.
- Issues related to health care pricing transparency.
- HR 3303, "Mobile Medical Application", regarding all provisions.
- HR 2085, "Diagnostic Payment Reform", regarding all provisions.
- Issues related to health care associated inflation policy.
- HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions.
- HR 3204, "Drug Quality and Security Act", regarding all provisions.
- Issues related to neglected tropical diseases.
- Issues related to transferable market exclusivity.
- HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions.
- Issues related to health care associated infections.
- S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions.
- Issues related to FDA regulation of custom medical devices.
- Issues related to Tricare coverage of Total Disc Arthroplasty.
- Issues related to VA requirements for vendor access and credentialing.
- Issues related to 21st Century Cures.
- Issues related to Medicare beneficiary access.
- Issues related to mobile medical applications and digital healthcare.
- Issues related to FDA draft guidances on blood glucose meters.
- HR 4895, "The Microbead Free Waters Act of 2014", regarding all provisions.
- Issues related to the expanded use of unapproved drugs.
Client expense: $1,060,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program funding -- S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014
Implementation of the Affordable Care and Health Care & Education Affordability Reconciliation Act of 2010 (PL 111-148 and 111-152); diabetes screening
Human growth hormone and rare disease matters
HR 1074/S 539 - National Diabetes Clinical Care Commission Act of 2013
HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013
HR 1915/S 907 - Gestational Diabetes Act of 2013
Client expense: Not reported · Firm income: $27,000
Cited source text, amounts, lobbyists, and targets
H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Client expense: Not reported · Firm income: $20,000